Is Nvidia Stock a Buy?

Nvidia reported fiscal Q1 2027 revenue of $81.6 billion, up 85% year over year, with data center revenue rising 92% to $75.2 billion and accounting for more than 90% of sales. Management guided to about $91 billion in fiscal Q2 revenue, but that outlook assumes no China data center compute revenue, highlighting a key geopolitical risk. The company also maintained strong shareholder returns, sending back about $20 billion and authorizing another $80 billion in buybacks.

Analysis

The market is treating NVDA less like a hardware vendor and more like a toll collector on AI infrastructure spend, which is why the stock can flatten even while fundamentals re-accelerate. The important second-order effect is that customer self-supply does not necessarily displace near-term demand; it can instead broaden Nvidia’s effective moat if its software, networking, and system-level integration remain the easiest path to deployment. That said, the upside path is increasingly tied to how long hyperscalers accept Nvidia’s pricing rather than whether they can technically design alternatives.

The cleanest incremental risk is not a demand miss, but a margin/working-capital normalization if the mix shifts from scarce, high-margin training builds to a more competitive inference market over the next 6-18 months. China is also more than a lost revenue line: it removes a reference customer set that historically validated scale economics, and it may indirectly weaken ecosystem momentum if local substitutes gain installed base and developer attention. For AMD, the issue is less near-term unit share and more the valuation trap of being a “good enough” alternative in a market where buyers still optimize for time-to-deployment and software reliability.

The contrarian setup is that consensus may be underestimating how much of NVDA’s capex cycle is still ahead, not behind. If current guidance is truly excluding China entirely, any policy easing or license normalization would function as a positive surprise with very high operating leverage. The market appears to be discounting a plateau in AI spend; a more plausible base case is spend rotation from training into inference and sovereign/enterprise deployments, which can sustain revenue growth longer than investors expect, even if headline hypergrowth moderates.

Key Decisions for Investors

• Maintain a core long NVDA, but finance it by selling upside: buy 6-12 month-dated calls or stock, and overwrite into strength against strikes 10-15% above spot. Risk/reward favors participation in the base case while reducing the chance of paying peak multiple for a momentum squeeze.
• Pair trade: long NVDA / short AMD over the next 3-9 months. NVDA has stronger execution visibility and ecosystem lock-in; AMD’s upside depends on customers actually switching procurement behavior, which tends to lag product competitiveness by multiple quarters.
• Add a tactical long INTC as a low-conviction hedge on domestic supply-chain localization and export-control spillovers. If geopolitical restrictions tighten further, any foundry/packaging substitution narrative can lift INTC before it materially threatens NVDA share.
• For event risk, buy downside protection on NVDA into the next earnings window rather than selling the equity outright. A 10-12% drawdown is plausible on any hint of gross margin compression or hyperscaler capex digestion, but the structural trend remains intact.
• If China policy headlines improve, express it with short-dated call spreads on NVDA rather than outright stock. The upside from a license normalization headline could re-rate the name quickly, but the trade should be sized as a catalyst, not a thesis change.